• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用小肽变构破坏CDK2/细胞周期蛋白E1界面。

Break CDK2/Cyclin E1 interface allosterically with small peptides.

作者信息

Chen Hao, Zhao Yunjie, Li Haotian, Zhang Dongyan, Huang Yanzhao, Shen Qi, Van Duyne Rachel, Kashanchi Fatah, Zeng Chen, Liu Shiyong

机构信息

Department of Physics, The George Washington University, Washington, D. C., United States of America.

Department of Physics, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

PLoS One. 2014 Oct 7;9(10):e109154. doi: 10.1371/journal.pone.0109154. eCollection 2014.

DOI:10.1371/journal.pone.0109154
PMID:25290691
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4188581/
Abstract

Most inhibitors of Cyclin-dependent kinase 2 (CDK2) target its ATP-binding pocket. It is difficult, however, to use this pocket to design very specific inhibitors because this catalytic pocket is highly conserved in the protein family of CDKs. Here we report some short peptides targeting a noncatalytic pocket near the interface of the CDK2/Cyclin complex. Docking and molecular dynamics simulations were used to select the peptides, and detailed dynamical network analysis revealed that these peptides weaken the complex formation via allosteric interactions. Our experiments showed that upon binding to the noncatalytic pocket, these peptides break the CDK2/Cyclin complex partially and diminish its kinase activity in vitro. The binding affinity of these peptides measured by Surface Plasmon Resonance can reach as low as 0.5 µM.

摘要

大多数细胞周期蛋白依赖性激酶2(CDK2)抑制剂靶向其ATP结合口袋。然而,利用这个口袋设计高度特异性的抑制剂很困难,因为这个催化口袋在CDK蛋白家族中高度保守。在这里,我们报道了一些靶向CDK2/细胞周期蛋白复合物界面附近非催化口袋的短肽。通过对接和分子动力学模拟来选择这些肽,详细的动力学网络分析表明,这些肽通过变构相互作用削弱复合物的形成。我们的实验表明,这些肽与非催化口袋结合后,会部分破坏CDK2/细胞周期蛋白复合物,并在体外降低其激酶活性。通过表面等离子体共振测量,这些肽的结合亲和力可低至0.5μM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/e1fcbc15ea11/pone.0109154.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/8b213b8ccee7/pone.0109154.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/9f23def62263/pone.0109154.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/50d9fa2914a6/pone.0109154.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/39915cc65a69/pone.0109154.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/e1fcbc15ea11/pone.0109154.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/8b213b8ccee7/pone.0109154.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/9f23def62263/pone.0109154.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/50d9fa2914a6/pone.0109154.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/39915cc65a69/pone.0109154.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/4188581/e1fcbc15ea11/pone.0109154.g005.jpg

相似文献

1
Break CDK2/Cyclin E1 interface allosterically with small peptides.利用小肽变构破坏CDK2/细胞周期蛋白E1界面。
PLoS One. 2014 Oct 7;9(10):e109154. doi: 10.1371/journal.pone.0109154. eCollection 2014.
2
A novel binding pocket of cyclin-dependent kinase 2.细胞周期蛋白依赖性激酶2的一个新型结合口袋。
Proteins. 2009 Jan;74(1):122-32. doi: 10.1002/prot.22136.
3
Why are the truncated cyclin Es more effective CDK2 activators than the full-length isoforms?截短的细胞周期蛋白 E 为何比全长同工型更有效地激活 CDK2?
Biochemistry. 2014 Jul 22;53(28):4612-24. doi: 10.1021/bi5004052. Epub 2014 Jul 10.
4
Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays.通过虚拟筛选和生物测定发现新型非肽变构抑制剂阻断CDK2/细胞周期蛋白A3的相互作用。
Bioorg Med Chem Lett. 2015 Oct 1;25(19):4069-73. doi: 10.1016/j.bmcl.2015.08.050. Epub 2015 Aug 20.
5
Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.环丁基取代咪唑抑制剂对 CDK 选择性差异的分子基础:对合理药物设计的启示。
PLoS One. 2013 Sep 13;8(9):e73836. doi: 10.1371/journal.pone.0073836. eCollection 2013.
6
A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding.细胞周期蛋白依赖性激酶2的PSTAIRE螺旋区域中的癌症衍生突变改变了细胞周期蛋白结合的稳定性。
Biochim Biophys Acta. 2010 Jul;1803(7):858-64. doi: 10.1016/j.bbamcr.2010.04.004. Epub 2010 Apr 24.
7
Molecular dynamics and QM/MM-based 3D interaction analyses of cyclin-E inhibitors.基于分子动力学和QM/MM 的细胞周期蛋白 E 抑制剂的 3D 相互作用分析。
J Mol Model. 2013 Feb;19(2):879-91. doi: 10.1007/s00894-012-1620-z. Epub 2012 Oct 20.
8
Network-based modelling and percolation analysis of conformational dynamics and activation in the CDK2 and CDK4 proteins: dynamic and energetic polarization of the kinase lobes may determine divergence of the regulatory mechanisms.基于网络的CDK2和CDK4蛋白构象动力学与激活的建模及渗流分析:激酶结构域的动态和能量极化可能决定调节机制的差异。
Mol Biosyst. 2017 Oct 24;13(11):2235-2253. doi: 10.1039/c7mb00355b.
9
Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.基于结构的细胞周期蛋白依赖性激酶2首个变构抑制剂的发现
Cell Cycle. 2014;13(14):2296-305. doi: 10.4161/cc.29295. Epub 2014 Jun 9.
10
Discovery of a potential allosteric ligand binding site in CDK2.发现 CDK2 中的一个潜在别构配体结合位点。
ACS Chem Biol. 2011 May 20;6(5):492-501. doi: 10.1021/cb100410m. Epub 2011 Feb 22.

引用本文的文献

1
Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception.以细胞周期蛋白依赖性激酶2(CDK2)与细胞周期蛋白及Speedy 1(Spy1)的相互作用为靶点用于癌症治疗和男性避孕。
Future Med Chem. 2025 Mar;17(5):607-627. doi: 10.1080/17568919.2025.2463868. Epub 2025 Mar 4.
2
HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules.使用小分子RNA结合分子抑制HIV-1转录
Pharmaceuticals (Basel). 2023 Dec 25;17(1):33. doi: 10.3390/ph17010033.
3
Unveiling the noncanonical activation mechanism of CDKs: insights from recent structural studies.

本文引用的文献

1
Peptide docking and structure-based characterization of peptide binding: from knowledge to know-how.肽对接和基于结构的肽结合特征化:从知识到实践。
Curr Opin Struct Biol. 2013 Dec;23(6):894-902. doi: 10.1016/j.sbi.2013.07.006. Epub 2013 Oct 15.
2
Computational design of helical peptides targeting TNFα.靶向 TNFα 的螺旋肽的计算设计。
Angew Chem Int Ed Engl. 2013 Oct 11;52(42):11059-62. doi: 10.1002/anie.201305963. Epub 2013 Aug 26.
3
Protein-peptide complex prediction through fragment interaction patterns.通过片段相互作用模式预测蛋白质-肽复合物。
揭示细胞周期蛋白依赖性激酶的非经典激活机制:近期结构研究的见解
Front Mol Biosci. 2023 Nov 9;10:1290631. doi: 10.3389/fmolb.2023.1290631. eCollection 2023.
4
Emerging approaches to CDK inhibitor development, a structural perspective.从结构角度看CDK抑制剂开发的新兴方法。
RSC Chem Biol. 2022 Dec 14;4(2):146-164. doi: 10.1039/d2cb00201a. eCollection 2023 Feb 8.
5
Novel method to identify group-specific non-catalytic pockets of human kinome for drug design.用于药物设计的鉴定人类激酶组中组特异性非催化口袋的新方法。
RSC Adv. 2020 Jan 10;10(4):2004-2015. doi: 10.1039/c9ra07471f. eCollection 2020 Jan 8.
6
LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b.长链非编码 RNA MAGI2-As3 通过海绵吸附 miR-15b 抑制宫颈癌的增殖和侵袭。
J Healthc Eng. 2022 Jan 25;2022:9707206. doi: 10.1155/2022/9707206. eCollection 2022.
7
The TAR binding dynamics and its implication in Tat degradation mechanism.TAR 结合动力学及其在 Tat 降解机制中的意义。
Biophys J. 2021 Dec 7;120(23):5158-5168. doi: 10.1016/j.bpj.2021.11.006. Epub 2021 Nov 9.
8
Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†.针对环细胞依赖性激酶 2(CDK2)作为男性避孕药的原理和进展综述†。
Biol Reprod. 2020 Aug 4;103(2):357-367. doi: 10.1093/biolre/ioaa107.
9
HKPocket: human kinase pocket database for drug design.HKPocket:用于药物设计的人类激酶口袋数据库。
BMC Bioinformatics. 2019 Nov 29;20(1):617. doi: 10.1186/s12859-019-3254-y.
10
DIRECT: RNA contact predictions by integrating structural patterns.直接:通过整合结构模式进行 RNA 接触预测。
BMC Bioinformatics. 2019 Oct 15;20(1):497. doi: 10.1186/s12859-019-3099-4.
Structure. 2013 May 7;21(5):789-97. doi: 10.1016/j.str.2013.02.023. Epub 2013 Apr 11.
4
A unified conformational selection and induced fit approach to protein-peptide docking.一种统一的构象选择和诱导契合方法用于蛋白质-肽对接。
PLoS One. 2013;8(3):e58769. doi: 10.1371/journal.pone.0058769. Epub 2013 Mar 13.
5
Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.基于生物物理和计算的片段方法靶向蛋白质-蛋白质相互作用:在结构导向药物发现中的应用。
Q Rev Biophys. 2012 Nov;45(4):383-426. doi: 10.1017/S0033583512000108. Epub 2012 Sep 13.
6
Combining coarse-grained nonbonded and atomistic bonded interactions for protein modeling.结合粗粒度非键相互作用和原子键相互作用进行蛋白质建模。
Proteins. 2013 Jan;81(1):81-92. doi: 10.1002/prot.24164. Epub 2012 Sep 26.
7
Structural and dynamic determinants of protein-peptide recognition.蛋白质-肽识别的结构和动力学决定因素。
Structure. 2011 Dec 7;19(12):1837-45. doi: 10.1016/j.str.2011.09.014.
8
Rosetta FlexPepDock web server--high resolution modeling of peptide-protein interactions.Rosetta FlexPepDock 网页服务器——肽-蛋白相互作用的高分辨率建模。
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W249-53. doi: 10.1093/nar/gkr431. Epub 2011 May 27.
9
Computational design of proteins targeting the conserved stem region of influenza hemagglutinin.针对流感血凝素保守茎区的蛋白质的计算设计。
Science. 2011 May 13;332(6031):816-21. doi: 10.1126/science.1202617.
10
Computational design of peptide ligands.肽配体的计算设计。
Trends Biotechnol. 2011 May;29(5):231-9. doi: 10.1016/j.tibtech.2011.01.004. Epub 2011 Feb 12.